Krystexxa 8MG

Ended Awarded

Contract number
36C24523N0938
Awardee
Awarding agency
Obligated
$89,856

Award facts

Contract value 100% obligated
$89,856.45 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
La Vergne, TN 37086, USA

Award details come from SAM.gov/FPDS.

About this award

The Department of Veterans Affairs Veterans Health Administration awarded Horizon Therapeutics USA Inc. a $89,856 delivery order against the company's Pharmaceuticals and Drugs GSA Schedule contract. The order is to provide KRYSTEXXA 8MG for use by VHA's Veterans Integrated Service Network 5 based in La Vergne, Tennessee. The firm fixed price order runs from September 20-22, 2023 and will supply the specialty drug to support VHA's healthcare services for veterans in the region. No subcontractors or set-aside designations were identified in the award information.

Quick answers

Who was awarded contract 36C24523N0938?

36C24523N0938 was awarded to Horizon Therapeutics Usa, Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on September 20, 2023.

How much is contract 36C24523N0938 worth?

The government has obligated $89,856 on 36C24523N0938.

Is contract 36C24523N0938 an order under another contract?

Yes. 36C24523N0938 is a delivery order under 36F79719D0224, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C24523N0938 competed?

The extent of competition for 36C24523N0938 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award